Heron Therapeutics
HRTX
#7197
Rank
A$0.62 B
Marketcap
$4.09
Share price
13.84%
Change (1 day)
3.94%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.76

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.88. In 2022 the company made an earnings per share (EPS) of -$2.77 an increase over its 2021 EPS that were of -$3.61.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.76-36.41%
2022-$2.77-23.11%
2021-$3.61-10%
2020-$4.01-0%
2019-$4.011.21%
2018-$3.96-32.7%
2017-$5.88-19.34%
2016-$7.3054.76%
2015-$4.711.73%
2014-$4.63-16.23%
2013-$5.5391.67%
2012-$2.89-31.45%
2011-$4.21-27.06%
2010-$5.77-43.75%
2009-$10.26-57.33%
2008-$24.05-82.92%
2007-$140.7820.61%
2006-$116.73175.76%
2005-$42.33-21.43%
2004-$53.87100%
2003-$26.94-38.24%
2002-$43.61161.54%
2001-$16.68-106.46%
2000$257.982051.55%
1999$11.99839.73%
1998$1.28-105.48%
1997-$23.30-88.16%
1996-$196.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.08-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.22-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.61 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.52-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.65 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA